Approval of Respiratory Biologics Linked to Decline in Asthma Exacerbations | ClinicLens

The approval of additional respiratory biologics for asthma was associated with a significant decline in exacerbations, a study published in JAMA Network Open found.

Medical Literature · Updated 2026-08-10

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.